Cardiovascular Disease

>

Latest News

Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia / Image credit: ©Lumos/AdobeStock
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia

September 27th 2023

Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.

GLP-1RAs, SGLT2-Is Understudied in Black Populations in Pivotal Trials, Benefits Questioned  / image credit mbz1/stock.adobe.com
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned

September 26th 2023

Biosimilar Liraglutide Noninferior to Reference Product in Persons with Type 2 Diabetes: Phase 3 Trial image credit ©PARATA/stock.adobe.com
Biosimilar Liraglutide Noninferior to Reference Product in Persons with Type 2 Diabetes: Phase 3 Trial

September 25th 2023

Novel Factor XI Inhibitor Abelacimab Found Superior to Rivaroxaban in Phase 2b Trial with High-Risk Cohort image Marc Sabatine, MD, MPH, Courtesy of BWH
Novel Factor XI Inhibitor Abelacimab Found Superior to Rivaroxaban in Phase 2b Trial with High-Risk Cohort

September 19th 2023

Daily Dose: "Night Owls" Less Healthy, at Higher Risk for T2D / image credit folders-stethoscope  ©New Africa/AdobeStock
Daily Dose: High Blood Pressure While Lying Down Raises Risk for CVD Events

September 18th 2023

Latest CME Events & Activities

7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

Register Now!

Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?

View More

Clinical Consultations: Improving Outcomes By Addressing Health Care Disparities in Heart Failure Care

View More

Understanding Best Care Practices for Hemorrhagic Stroke – A Focus on the Role of DOAC Reversals

View More

Addressing Healthcare Inequities in Cardiac Amyloidosis: Interventions Aimed at Improving Care for All Patients

View More

The 6th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

View More

Transfusion-Related Iron Overload–Evidence-Based Approaches to Improve Chelation Outcomes

View More

Community Practice Connections™: Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

View More

Amplifying the Role of Accurate Diagnosis and New Therapeutic Options in the Treatment of Hemolytic Anemias

View More

Medical Crossfire®: Updates in Continuous Glucose Monitoring—Having the Important Conversations With Your Patients

View More

Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities

View More

More News

© 2023 MJH Life Sciences

All rights reserved.